Thursday, November 19, 2009
Print Current Session:
|
|
Thursday
SESSION XIX:
UPDATES AND NEW CONCEPTS IN VASCULAR DISEASE (5-MINUTE TALKS)
Moderators:Daniel G. Clair, MD / Frank J. Veith, MD
|
|
SESSION XIX SCHEDULE | |
5:26 PM - 5:31 PM | 2-3-Year Results With Drug Eluting Stents (DES): Does Catch-Up Stenosis And Mortality Occur And Why? |
Presenters(s):Julio C. Palmaz, MD | |
5:32 PM - 5:37 PM | Midterm Efficacy And Long-Term Outlook With Coronary Drug Eluting Stents And Absorbable Drug Eluting Stents (The ABSORB Trial): Is There A Downside Beside Costs? |
Presenters(s):Martin B. Leon, MD | |
5:38 PM - 5:43 PM | Vulnerable Plaques: Implications For Vascular Surgeons And Interventionalists And What Can Be Done About Them? |
Presenters(s):Gregg W. Stone, MD | |
5:44 PM - 5:49 PM | Findings And Interpretations Of The SYNTAX Trial: Is It A Winner For Stenting Or CABG In Severe Coronary Artery Disease With Triple Vessel Or Left Main Disease? |
Presenters(s):Michael J. Mack, MD | |
5:50 PM - 5:55 PM | Will Biodegradable Stents Replace Drug Eluting Stents? |
Presenters(s):Ron Waksman, MD | |
5:56 PM - 6:01 PM | Surgical And Endovascular Treatment Of Takayasu’s Arteritis: Which Treatment Should Be Used And When? |
Presenters(s):Xiaoyun Luo, MD / Qinghua Wu, MD | |
6:02 PM - 6:07 PM | Radiation Exposure To The Interventionalist: Innovations And Precautions To Lessen It |
Presenters(s):Timur P. Sarac, MD | |
6:08 PM - 6:13 PM | Panel Discussion |
END OF SESSION XIX | |
previous | next |